Ultrasound Conference
About the Event
Date:November 14–15, 2024
Location:Washington, D.C.
Credit:CME: 15.00; ABIM MOC: 15.00
On Demand:Not Available
This intensive, two-day, pre-ACR Convergence conference is designed to meet the specific educational needs of rheumatology professionals who want to learn ultrasound technology. Under the guidance of experts from around the world, attendees will perform hands-on scanning of live models to enhance technical proficiency for the diagnosis of normal and abnormal clinical conditions. At the completion of this course, attendees should be able to demonstrate familiarity with the anatomy, physiology, and pathophysiology of the shoulder, elbow, hand, wrist, hip, knee, foot, and ankle, and ultrasound guidance of aspirations, injections, and biopsies.
Ultrasound Conference Courses
Two courses will be offered. Each course will take place over two days, on November 14–15. Select either:
- Basic-Intermediate Musculoskeletal Ultrasound Course or
- Advanced Ultrasound: Inflammatory Arthropathies, Lupus, Sjögren's Disease, Interstitial Lung Disease, and Vasculitis
Both novice and advanced learners are encouraged to join one of the courses. Although documentation is not required, some basic experience in rheumatologic joint sonography is recommended as a prerequisite for the Advanced Ultrasound course.
Target Audience
This activity is intended for rheumatology professionals with a beginner to low intermediate level of ultrasound experience, or rheumatology professionals with ultrasound experience interested in advanced learning opportunities. To provide an optimal learning environment, attendance is limited.
Learning Objectives
Upon completion of the Basic-Intermediate Course, participants should be able to:
- Recognize indications for the use of ultrasound in rheumatology practice
- Incorporate the use of ultrasound in their practice
- Acquire reliable and consistent ultrasound images of basic-intermediate level elementary lesions
- Interpret ultrasound images adequately in a manner that informs clinical decision making and patient education
- Incorporate ultrasound guidance into joint and tendon injection procedure
Upon completion of the Advanced Course, participants should be able to:
- Recognize ultrasound pathology related to various types of rheumatic conditions
- Acquire and interpret ultrasound images of various rheumatic conditions using validated scoring systems
- Engage in more effective shared decision-making processes with patients with the information provided by ultrasound images acquired at the point of care
- Recognize more advanced ultrasound guided procedural techniques
- Incorporate effective dynamic maneuvers to improve image acquisition
Featured Speakers
Jemima Albayda, MD, RhMSUS
Associate Professor of Medicine; Director, Rheumatology Fellowship Program; Director, Musculoskeletal Ultrasound and Injection Clinic, Johns Hopkins University
Eugene Kissin, MD, RhMSUS
Rheumatology Fellowship Program Director, Boston University Medical Center
Gurjit Kaeley, MBBS, RhMSUS, MRCP
Division Chief, Professor of Medicine, Fellowship Program Director, Program Director for Musculoskeletal Ultrasound, University of Florida College of Medicine
Ralf Thiele, MD, RhMSUS
Associate Professor of Medicine, Rheumatology Division, University of Rochester
Janeth Yinh, MD, RhMSUS
Rheumatologist, Rheumatology Musculoskeletal Ultrasound Program, Massachusetts General Hospital
Planning Committee
Janeth Yinh, MD, RhMSUS
Chair, Ultrasound Course Planning Subcommittee
Chair, Basic-Intermediate Musculoskeletal Ultrasound Course
Fawad Aslam, FACP, FACR, MBBS, MSc, RhMSUS
Chair, Advanced Rheumatologic Ultrasound Course
Heather Benham, RhMSUS, APRN, CPNP
David Bulbin, DO, RhMSUS, FACR
Erin Chew, MD, RhMSUS
Philip Chu, MD, RhMSUS
Lily Kao, MD, RhMSUS
Program Schedule & Syllabi
Ultrasound Conference Program Schedule
Registered attendees can access the syllabi during the meeting and for 12 months after the meeting. To access syllabi, login and go to My Learning.
View the full ACR Convergence program
Registration Fees
ACR/ARP Member: $1,995
Potential Member: $2,495
Hotel & Travel
The Ultrasound Conference will take place at the Marriott Marquis in Washington, D.C., on November 14–15.
Marriott Marquis
901 Massachusetts Ave NW
Washington, D.C. 20001
Hotel reservations can be made via the registration link.
View the hotel map and rates and information about traveling to Washington, D.C.
Corporate Support
The American College of Rheumatology thanks our corporate supporters and partners for their commitment to advancing rheumatology by supporting ACR and ARP programs and initiatives.
Interested in Exhibiting or Sponsorship?
Support this pre-ACR Convergence event and connect with a focused group of attendees as an exhibitor and/or sponsor, or support with in-kind equipment. View the Exhibitor and Sponsorship Prospectus and contact Kat Dennis (kdennis@rheumatology.org) with questions or to secure your spot.
Commercial Support Disclosure: This activity is supported in part by an unrestricted educational grant from the following companies: Janssen Pharmaceuticals, Pfizer
See current supporters, guidelines, and benefits of supporting the ACR.
CME
Accreditation Statement
The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
See the ACR’s CME Mission Statement. For more information, download the AMA PRA Booklet.
Designation Statement
The ACR designates this Live Activity for a maximum of 15.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CME credit must be claimed by January 31, 2025.
MOC
MOC Recognition Statement: American Board of Internal Medicine (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 15.00 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board.
After submitting a reflective statement with key takeaways from the meeting, MOC points will be applied for ABIM diplomates to the ABIM diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABIM Physician Portal. Please allow at least 48 hours for points to display in the portal.
MOC points must be claimed by January 31, 2025.
Credit claiming is available after the activity starts.
How to Receive Credit
In order to qualify for Continuing Medical Education (CME) and Maintenance of Certification (MOC) credits, please ensure that you complete the following requirements:
- Pre-Test Survey: A link to the survey will be sent to learners prior to the activity.
- Post-Test Survey: After the activity, learners are required to complete a post-test survey, achieving a passing score of 70% or higher. Learners are permitted up to five attempts to achieve this score. A link to the survey will be emails to learners 30 minutes prior to the conclusion of the activity.
- Activity Evaluation: A separate link for the evaluation will be emailed to learners. Upon completion, a certificate will be available for learners to print or save.
Note: The deadline for learners to complete all tasks is January 31, 2025.
Questions? Contact education@rheumatology.org.
ACR Disclosure Statement
It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.
Nature of Financial Relationships
All individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:
- Advisor or review panel member
- Consultant
- Employee
- Officer or Board Member
- Grant/research support
- Speaker/honoraria includes speakers bureau, symposia, and expert witness
- Independent contractor
- Executive role and/or ownership interest
- Royalties and/or patient beneficiary
- Intellectual property/patents
- Stock options or bond holdings in a for-profit corporation or self-directed pension plan
- Private investigator
- Expert witness
- Equity interest
- Other: specify details
None: Has no relevant financial relationship(s) with ineligible companies to disclose.
The planning committee and faculty reported the following disclosures.
Ultrasound Conference 2024 Financial Relationships Disclosures
View ACR's ACCME disclosure practices
*All of the relevant financial relationships listed for these individuals have been mitigated.